Squarepoint’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9,734
Closed -$203K 3767
2022
Q3
$203K Buy
+9,734
New +$203K ﹤0.01% 2689
2022
Q2
Sell
-58,457
Closed -$981K 3604
2022
Q1
$981K Buy
58,457
+45,898
+365% +$802K ﹤0.01% 1600
2021
Q4
$251K Sell
12,559
-149,300
-92% -$2.81M ﹤0.01% 2554
2021
Q3
$2.94M Buy
161,859
+124,580
+334% +$2.86M 0.01% 1014
2021
Q2
$1.01M Buy
+37,279
New +$1.04M ﹤0.01% 1623
2020
Q2
Sell
-11,967
Closed -$97K 2619
2020
Q1
$97K Sell
11,967
-53,256
-82% -$608K ﹤0.01% 1645
2019
Q4
$861K Buy
+65,223
New +$790K 0.01% 1435

Other funds holding CVET

Squarepoint's CVET Position: Q4 2022 in Review

Squarepoint sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 9,734 shares — an estimated $203K sold.

Squarepoint first reported a position in CVET in Q4 2019 and held it in 7 quarters. The position peaked at $2.94M in Q3 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Squarepoint reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Squarepoint sold 9,734 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $203K.
  • Squarepoint first reported a position in Covetrus, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Squarepoint's Covetrus, Inc. Common Stock position peaked at $2.94M in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Squarepoint's 13F filing for Q4 2022, filed 14 Feb 2023.